The role of inflammation in CNS injury and disease

British Journal of Pharmacology

Volumn 147, Issue SUPPL. 1, 2006, Pages

  Lucas, Sian Marie ^a   Rothwell, Nancy J ^a   Gibson, Rosemary M ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HEALTH AND SAFETY LABORATORY   (United Kingdom)

Author keywords

Complement; COX; Cytokine; Interleukin; Neurodegeneration; NO; Tumour necrosis factor

Indexed keywords

BETA INTERFERON; CASPASE INHIBITOR; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; FREE RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MINOCYCLINE; NALOXONE; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;

ALZHEIMER DISEASE; BRAIN DISEASE; BRAIN INJURY; ENVIRONMENTAL FACTOR; EPILEPSY; GENETICS; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; STROKE;

ACUTE DISEASE; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; CHRONIC DISEASE; CRANIOCEREBRAL TRAUMA; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 30444459031     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706400     Document Type: Review

References (37)

1. AISEN, P.S., SCHAFER, K.A., GRUNDMAN, M., PFEIFFER, E., SANO, M., DAVIS, K.L., FARLOW, M.R., JIN, S., THOMAS, R.G. & THAL, L.J. (2003). Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA, 289, 2819-2826.
2. BALOSSO, S., RAVIZZA, T., PEREGO, C., PESCHON, J., CAMPBELL, I.L., DE SIMONI, M.G. & VEZZANI, A. (2005). Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann. Neurol., 57, 804-812.
3. BECKER, K., KINDRICK, D., RELTON, J.K., HARLAN, J.M. & WINN, R. (2001). Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke, 32, 206-211.
4. CAMPBELL, A. (2004). Inflammation, neurodegenerative diseases, and environmental exposures. Ann. N.Y. Acad. Sci, 1035, 117-132.
5. COUZIN, J. (2004). Clinical trials. Nail-biting time for trials of COX-2 drugs. Science, 306, 1673-1675.
6. DE SIMONI, M.G., STORINI, C., BARBA, M., CATAPANO, L., ARABIA, A.M., ROSSI, E. & BERGAMASCHINI, L. (2003). Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J. Cereb. Blood Flow Metab., 23, 232-239.
7. FAULKNER, J.R., HERRMANN, J.E., WOO, M.J., TANSEY, K.E., DOAN, N.B. & SOFRONIEW, M.V. (2004). Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci., 24, 2143-2155.
8. GAO, H.M., LIU, B., ZHANG, W. & HONG, J.S. (2003). Novel anti-inflammatory therapy for Parkinson's disease. Trench Pharmacol. Sci., 24, 395-401.
9. GILDEN, D.H. (2005). Infectious causes of multiple sclerosis. Lancet Neurol., 4, 195-202.
10. HALLENBECK, J.M. (2002). The many faces of tumor necrosis factor in stroke. Nat. Med., 8, 1363-1368.
11. HANSON, D.R. & GOTTESMAN, I.I. (2005). Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med. Genet., 6, 7.
12. HUITINGA, I., SCHMIDT, E.D., VAN DER CAMMEN, M.J., BINNEKADE, R. & TILDERS, F.J. (2000). Priming with interleukin-1beta suppresses experimental allergic encephalomyelitis in the Lewis rat. J. Neuroendocrinol., 12, 1186-1193.
13. LIAO, J.K. & LAUFS, U. (2005). Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol., 45, 89-118.
14. MCGEER, P.L. & MCGEER, E.G. (2004). Inflammation and the degenerative diseases of aging. Ann. N. Y. Acad. Sci, 1035, 104-116.
15. MCGEER, P.L., SCHULZER, M. & MCGEER, E.G. (1996). Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology, 47, 425-432.
16. MORO, M.A., CARDENAS, A., HURTADO, O., LEZA, J.C. & LIZASOAIN, I. (2004). Role of nitric oxide after brain ischaemia. Cell Calcium, 36, 265-275.
17. MYCKO, M.P., PAPOIAN, R., BOSCHERT, U., RAINE, C.S. & SELMAJ, K.W. (2003). cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain, 126, 1048-1057.
18. PERRY, V.H. (2004). The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav. Immun., 18, 407-413.
19. PIRAINO, P.S., YEDNOCK, T.A., FREEDMAN, S.B., MESSERSMITH, E.K., PLEISS, M.A., VANDEVERT, C., THORSETT, E.D. & KARLIK, S.J. (2002). Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of alpha4 integrin. J. Neuroimmunol., 131, 147-159.
20. POLLMACHER, T., HAACK, M., SCHULD, A., REICHENBERG, A. & YIRMIYA, R. (2002). Low levels of circulating inflammatory cytokines - do they affect human brain functions? Brain Behav. Immun., 16, 525-532.
21. RAINERO, I., BO, M., FERRERO, M., VALFRE, W., VAULA, G. & PINESSI, L. (2004). Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis. Neurobiol Aging, 25, 1293-1298.
22. RAIVICH, G. & BANATI, R. (2004). Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res. Brain Res. Rev., 46, 261-281.
23. ROTHWELL, N.J. & LUHESHI, G.N. (2000). Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci., 23, 618-625.
24. SAMLAND, H., HUITRON-RESENDIZ, S., MASLIAH, E., CRIADO, J., HENRIKSEN, S.J. & CAMPBELL, I.L. (2003). Profound increase in sensitivity to glutamatergic - but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J. Neurosci. Res., 73, 176-187.
25. SAYYAH, M., BEHESHTI, S., SHOKRGOZAR, M.A., ESLAMI-FAR, A., DELJOO, Z., KHABIRI, A.R. & HAERI, R.A. (2005). Antiepileptogenic and anticonvulsant activity of interleukin-1 beta in amygdala-kindled rats. Exp. Neurol., 191, 145-153.
26. SCHERBEL, U., RAGHUPATHI, R., NAKAMURA, M., SAATMAN, K.E., TROJANOWSKI, J.Q., NEUGEBAUER, E., MARINO, M.W. & MCINTOSH, T.K. (1999). Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci, 96, 8721-8726.
27. SEWELL, D.L., NACEWICZ, B., LIU, F., MACVILAY, S., ERDEI, A., LAMBRIS, J.D., SANDOR, M. & FABRY, Z. (2004). Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist. J. Neuroimmunol., 155, 55-63.
28. SHENG, J.G., GRIFFIN, W.S., ROYSTON, M.C. & MRAK, R.E. (1998). Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathol. Appl. Neurobiol, 24, 278-283.
29. STANISLAUS, R., SINGH, A.K. & SINGH, I. (2001). Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis. J. Neurosci. Res., 66, 155-162.
30. SUFFREDINI, A.F., FANTUZZI, G., BADOLATO, R., OPPENHEIM, J.J. & O'GRADY, N.P. (1999). New insights into the biology of the acute phase response. J. Clin. Immunol., 19, 203-214.
31. TAKEMIYA, T., SUZUKI, K., SUGIURA, H., YASUDA, S., YAMAGATA, K., KAWAKAMI, Y. & MARU, E. (2003). Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediat., 71, 205-216.
32. TEHRANIAN, R., NDELL-JONSSON, S., BENI, S.M., YATSIV, I., SHOHAMI, E., BARTFAI, T., LUNDKVIST, J. & IVERFELDT, K. (2002). Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J. Neurotrauma, 19, 939-951.
33. THE LENERCEPT MULTIPLE SCLEROSIS STUDY GROUP AND THE UNIVERSITY OF BRITISH COLUMBIA MS/MRI ANALYSIS GROUP (1999). TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology, 53, 457.
34. VAN, E.B., DEWULF, E., PALS, P., LUBKE, U., MARTIN, J.J. & CRAS, P. (2002). The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol. Aging, 23, 59-64.
35. VAN WAGONER, N.J. & BENVENISTE, E.N. (1999). Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol., 100, 124-139.
36. VEZZANI, A., MONETA, D., RICHICHI, C., ALIPRANDI, M., BURROWS, S.J., RAVIZZA, T., PEREGO, C. & DE SIMONI, M.G. (2002). Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia, 43 (Suppl 5), 30-35.
37. YOSHIHARA, T., ISHIGAKI, S., YAMAMOTO, M., LIANG, Y., NIWA, J., TAKEUCHI, H., DOYU, M. & SOBUE, G. (2002). Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem., 80, 158-167.